Inhibitor Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2013 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Inhibitor Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2013 to Q3 2024.
  • Inhibitor Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 12, 2024 was 172M shares, a 0.17% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 172M +300K +0.17% Nov 12, 2024 10-Q 2024-11-12
Q2 2024 172M +325K +0.19% Aug 6, 2024 10-Q 2024-08-06
Q1 2024 172M +230K +0.13% Mar 29, 2024 10-K 2024-03-29
Q3 2023 172M -205M -54.4% Nov 13, 2023 10-Q 2023-11-13
Q2 2023 172M -205M -54.4% Aug 11, 2023 10-Q 2023-08-11
Q1 2023 172M -205M -54.4% Mar 31, 2023 10-K 2023-03-31
Q3 2022 377M 0 0% Nov 14, 2022 10-Q 2022-11-14
Q2 2022 377M 0 0% Aug 12, 2022 10-Q 2022-08-12
Q1 2022 377M +982K +0.26% Mar 30, 2022 10-K 2022-03-30
Q3 2021 377M Nov 12, 2021 10-Q 2021-11-12
Q2 2021 377M +3.22M +0.86% Aug 13, 2021 10-Q 2021-08-13
Q1 2021 376M +5.43M +1.47% Mar 26, 2021 10-K 2021-03-26
Q4 2020 374M Nov 16, 2020 10-Q 2020-11-16
Q2 2020 374M +3.19M +0.86% Aug 12, 2020 10-Q 2020-08-12
Q1 2020 370M 0 0% Mar 30, 2020 10-K 2020-03-30
Q3 2019 370M +487K +0.13% Nov 6, 2019 10-Q 2019-11-07
Q2 2019 370M +487K +0.13% Aug 12, 2019 10-Q 2019-08-12
Q1 2019 370M +772K +0.21% Mar 7, 2019 10-K 2019-03-07
Q3 2018 370M +360K +0.1% Nov 13, 2018 10-Q 2018-11-14
Q2 2018 370M +360K +0.1% Jul 23, 2018 10-Q 2018-07-23
Q1 2018 370M +75K +0.02% May 1, 2018 10-Q 2018-05-01
Q3 2017 370M +69.2M +23% Oct 30, 2017 10-Q 2017-10-31
Q2 2017 370M +69.2M +23.1% Jul 28, 2017 10-Q 2017-07-31
Q1 2017 370M +101M +37.7% May 8, 2017 10-Q 2017-05-08
Q3 2016 300M +55.1M +22.5% Oct 31, 2016 10-Q 2016-10-31
Q2 2016 300M +55M +22.4% Aug 12, 2016 10-Q 2016-08-12
Q1 2016 268M +57M +26.9% May 12, 2016 10-Q 2016-05-13
Q4 2015 245M +33.9M +16.1% Feb 1, 2016 10-K 2016-02-01
Q3 2015 245M +33.9M +16.1% Nov 4, 2015 10-Q 2015-11-04
Q2 2015 245M +204M +492% Aug 14, 2015 10-Q 2015-08-14
Q1 2015 211M +193M +1019% May 13, 2015 10-Q 2015-05-13
Q4 2014 211M Feb 13, 2015 10-K 2015-02-13
Q3 2014 211M +193M +1019% Oct 10, 2014 10-Q 2014-10-10
Q2 2014 41.4M Aug 13, 2014 10-Q 2014-08-13
Q1 2014 18.9M Apr 11, 2014 10-K 2014-04-15
Q3 2013 18.9M Nov 14, 2013 10-Q 2013-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.